These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 3917279)

  • 1. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
    Thompson CB; Schaefer ME; Finkelman FD; Scher I; Farrar J; Mond JJ
    J Immunol; 1985 Jan; 134(1):369-74. PubMed ID: 3917279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
    Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
    J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
    Ennist DL; Elkins KL; Cheng SC; Howard M
    J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
    Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS
    J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
    Zubler RH; Erard F; Lees RK; Van Laer M; Mingari C; Moretta L; MacDonald HR
    J Immunol; 1985 Jun; 134(6):3662-8. PubMed ID: 3886789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
    Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
    J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies.
    MacDonald HR; Lees RK; Bron C
    J Immunol; 1985 Dec; 135(6):3944-50. PubMed ID: 2415592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors.
    Layton JE; Krammer PH; Hamaoka T; Uhr JW; Vitetta ES
    J Mol Cell Immunol; 1985; 2(3):155-67. PubMed ID: 2978227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.